Home » Authors » James Etheridge

Articles by James Etheridge

Synt:em Raises EUR22M To Support Product Development

March 21, 2001

By James Etheridge

Key Departure, Financials Send Genset's Stock Price Tumbling

March 14, 2001

By James Etheridge

Key Departure, Financials Send Genset's Stock Price Tumbling

March 14, 2001

By James Etheridge

DrugAbuse Reports Positive Phase II Results Of Naltrel

Feb. 21, 2001

By James Etheridge

DrugAbuse Reports Positive Phase II Results Of Naltrel

Feb. 21, 2001

By James Etheridge

Despite Resistance In France, Chirac Sees Place For GM Crops

Feb. 14, 2001

By James Etheridge

Hybrigenics, Servier Collaborate On Discovery Of Cancer Drugs

Feb. 14, 2001

By James Etheridge

Genset Cuts Back Genomics Focus, Moves On To Discovery

Feb. 14, 2001

By James Etheridge

French Advancing Legislation To Allow Therapeutic Cloning

Feb. 14, 2001

By James Etheridge

Despite Resistance In France, Chirac Sees Place For GM Crops

Feb. 14, 2001

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...